A review of the metabolic syndrome

Diabetes and Metabolism

Volumn 33, Issue 6, 2007, Pages 405-413

  Balkau, B ^a,b   Valensi, P ^c   Eschwege E ^a,b   Slama, G ^d,e  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Cardiovascular disease; Diabetes; Insulin resistance; Metabolic syndrome; Review

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTILIPEMIC AGENT; METFORMIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ATTENTION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIABETES MELLITUS; EVALUATION; HISTORY; HUMAN; INSULIN SENSITIVITY; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MEDICAL PROFESSION; METABOLIC SYNDROME X; MORBIDITY; PROSPECTIVE STUDY; PUBLIC HEALTH; REVIEW; SEX DIFFERENCE; SMOKING HABIT; INCIDENCE; LIFESTYLE; PATHOPHYSIOLOGY;

DIABETES MELLITUS; HUMANS; INCIDENCE; LIFE STYLE; METABOLIC SYNDROME X;

EID: 36749019149     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.08.001     Document Type: Review

References (39)

1. Ford E.S. Rarer than a blue moon: the use of a diagnostic code for the metabolic syndrome in the US. Diabetes Care 28 (2005) 1808-1809
2. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
3. Reaven G.M. The fourth musketeer - from Alexandre Dumas to Claude Bernard. Diabetologia 38 (1995) 3-13
4. Kylin E. Studien über das Hypertonie-Hyperglykämie-Hyperurika miesyndrom. Zentralblatt für Innere Medizin 44 (1923) 105-127
5. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 4 (1956) 20-34
6. Vague J. Sexual differentiation. A determinant factor of the forms of obesity. 1947. Obes. Res. 4 (1996) 201-203
7. Avogaro P., Crepaldi G., Enzi G., and Tiengo A. Associazione di iperlipidemia, diabete mellito e obesita de medio grado. Acto Diabetol Lat. 4 (1967) 36-41
8. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M., et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J. Clin. Invest. 75 (1985) 809-817
9. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
10. World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation (1999)
11. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 16 (1999) 442-443
12. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 102 (2000) 179-184
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
14. Einhorn D., Reaven G.M., Cobin R.H., Ford E., Ganda O.P., Handelsman Y., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr. Pract. 9 (2003) 237-252
15. IDF Consensus group. http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf, December 2006.
16. Alberti K.G., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet 366 (2005) 1059-1062
17. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and Management of the Metabolic Syndrome. An American Heart. Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
18. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation 112 (2005) e285-e290
19. Gomila S., and Dallongeville J. Epidémiologie du syndrome métabolique en France. Med. Nutr. 39 (2003) 89-94
20. Balkau B., Vernay M., Mhamdi L., Novak M., Arondel D., Vol S., et al., DESIR Study Group. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29 (2003) 526-532
21. Lean M.E., Han T.S., and Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ 311 (1995) 158-161
22. Wolf-Maier K., Cooper R.S., Banegas J.R., Giampaoli S., Hense H.W., Joffres M., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289 (2003) 2363-2369
23. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
24. Stern M.P., Williams K., and Hunt K.J. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease. Atheroscler. Suppl. 6 (2005) 3-6
25. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
26. Hillier T.A., Rousseau A., Lange C., Lepinay P., Cailleau M., Novak M., et al. Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis: the D.E.S.I.R. Cohort. Diabetologia 49 (2006) 1528-1535
27. Bataille V., Perret B., Dallongeville J., Arveiler D., Yarnell J., Ducimetiere P., et al. Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort. Diabetes Metab. 32 (2006) 475-479
28. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
29. Conroy R.M., Pyorala K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 24 (2003) 987-1003
30. Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., and Haffner S.M. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 27 (2004) 2676-2681
31. Balkau B., Qiao Q., Tuomilehto J., Borch-Johnsen K., and Pyöralä K. Does the metabolic syndrome detect further subjects at high risk of cardiovascular death, or is a conventional cardiovascular risk score adequate?. Diabetologia 48 (2005) A119
32. The DECODE Study Group. Does the diagnosis of the metabolic syndrome in non-diabetic men detect further subjects at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study. Eur. J. Cardiovasc. Prev. Rehabil. 14 (2007) 192-199
33. Hanson R.L., Imperatore G., Bennett P.H., and Knowler W.C. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51 (2002) 3120-3127
34. Hillier T.A., Fagot-Campagna A., Eschwège E., Vol S., Cailleau M., Balkau B., and the D.E.S.I.R. Study group. Weight change and changes in the metabolic syndrome as the French population moves towards overweight: The D.E.S.I.R. Cohort. Int. J. Epidemiol. 35 (2006) 190-196
35. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-304. Diabetologia 48 (2005) 1684-1699
36. Reaven G.M. The metabolic syndrome: requiescat in pace. Clin. Chem. 51 (2005) 931-938
37. Greenland P. Critical questions about the metabolic syndrome. Circulation 112 (2005) 3675-3676
38. Grundy S.M. Does the metabolic syndrome exist?. Diabetes Care 29 (2006) 1689-1692
39. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428